![Per Ingvar Oskar Wikström](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Per Ingvar Oskar Wikström is the founder and currently serves as the Chief Executive Officer & Director of Glucox Biotech AB, a company founded in 2003.
He has also held former positions as a Principal at Immunex Corp., Pfizer Inc., and Pharmacia, Inc.
Per Ingvar Oskar Wikström active positions
Companies | Position | Start |
---|---|---|
Glucox Biotech AB
![]() Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Founder | 30/06/2003 |
Former positions of Per Ingvar Oskar Wikström
Companies | Position | End |
---|---|---|
Pharmacia, Inc. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 3 |
---|---|
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Pharmacia, Inc. | |
Glucox Biotech AB
![]() Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Per Ingvar Oskar Wikström